PTC Therapeutics, Inc.
Treatment of pervasive developmental disorders with redox-active therapeutics

Last updated:

Abstract:

Methods of treating or suppressing pervasive developmental disorders (PDDs) including; autistic disorder, Asperger's syndrome, childhood disintegrative disorder (CDD), Rett's disorder, and PDD-not otherwise specified (PDD-NOS) or attention deficit/hyperactivity disorder (ADHD) comprising administering to a subject in need thereof a therapeutically effective amount of one or more compounds as disclosed herein.

Status:
Grant
Type:

Utility

Filling date:

19 Oct 2018

Issue date:

11 Aug 2020